Font Size:
a
A
A
Keyword [CCL22]
Result: 1 - 20 | Page: 1 of 2
1.
Effects Of Immunosuppressants And Ultraviolets On Secretion Of Chemokines By Keratinocytes
2.
CD4~+CD25~+ Regulatory T Lymphocytes In Tuberculous And Malignant Pleural Effusions
3.
Clinical Significance And Mechanism Of Up-Regulation Of CD4~+CD25~+FOXP3~+ Regulatory T Lymphocytes In Non-Small Cell Lung Cancer
4.
The Role Of Chemokine CCL22-CCR4 Axis And Milky Spots In Peritoneal Metastasis Of Gastric Cancer
5.
The Pathogenic And Clinical Roles Of Chemokines CCL22 And CCL27 In Systemic Lupus Erythematosus
6.
The Effect Of Autoimmune Regulator On Expression Of CCL22 In RAW264.7 Cells
7.
Expression Of Th1/Th2 Chemokines And Their Receptors In The Lesions Of Bullous Pemphigoid
8.
The Expression Of Chemokines CCL19,CCL22 And Cytoskeletal Proteins Fascin-1 By Dendritic Cells Pulsed With K-ras Mutant Peptide
9.
The Preliminary Study On The Imbalance Of Th1/Th2 Chemokines In Patient With Graves Disease
10.
The Contribution Of The CCl22, CCR4 In The Milky Spots Peritoneal -metastasis Of Gastric Cancer
11.
Trail On Tumor Invasion Run Cd4 + Cd25 ~~ + Treg Regulatory Role
12.
Effects Of
131
I Treatment On The Serum CXCL10ã€CCL22in Newly Onset Graves’ Disease
13.
The Distribution Of Th17Cells In Patients With Gastric Cancer And Its Regulation Mechanism
14.
Expressions Of Chemokine CCL22and Its Receptor CCR4and The Clinical Significance In Hapetocellular Carcinoma
15.
Regulation And Distribution Of Regulatory T Cells In Pancreatic Cancer And Its Spreading
16.
The Expression And Significance Of CCL22, FOXP3, IL-10 And IDO In B Cell Non-Hodgkin’s Lymphoma
17.
The Role Of STING In Progression Of HPV~+ Tongue Squamous Cell Carcinoma Patients
18.
The Role Of Peritoneal CD169~+ Macrophages In DSS-Induced Colitis
19.
The Expression Of CCR6-CCL20 Axis And CCR4-CCL22 Axis In Circulating Of Systemic Lupus Erythematosus Patients
20.
Mechanism Of CCL22 Downregulation By Fucoidan And The Effect On Macrophages Function And The Influence Factor Analysis Of Preoperative Neutrophil-lymphocyte Ratio As A Tumor Prognostic Index
<<First
<Prev
Next>
Last>>
Jump to